Author name: admin

Event

Advancing Clinical Practice Through Knowledge, Collaboration, and Continuous Improvement

Advancing Clinical Practice Through Knowledge, Collaboration, and Continuous Improvement At Ionic Global Sdn Bhd (IG), we believe that meaningful progress in healthcare is built through continuous learning, collaboration, and a shared commitment to improving patient outcomes. This partnership with PERDIM represents a step forward in building a healthier, more informed, and resilient society for the future. Following our engagement with PERDIM, we were honoured to further our journey with the Malaysian Doctors of Circumcision Society (MADOCS) during its Continuing Medical Education (CME) session on 26 April 2026. This engagement reflects our ongoing dedication to supporting the medical community through knowledge exchange and evidence-informed initiatives. The session brought together healthcare professionals with a shared objective—to enhance clinical practices through structured discussion, practical insights, and collaborative exploration of improvement opportunities. Representing Ionic Global, our leading wound care consultant, Dr. Clement Apong, together with Director Mr. Baharinshah Hussain and Business Development Advisor Mdm Monica Low, presented on key aspects of circumcision procedures. The discussion focused on gap analysis within current practices, identification of opportunity areas for enhancement, and the role of data management and analysis in supporting more consistent and reliable clinical outcomes. From a clinical perspective, variability in procedural techniques and post-operative care can influence healing progression, patient comfort, and complication rates. As such, the session emphasised the importance of adopting a more structured and standardised framework—one that is guided by data, practitioner experience, and evolving clinical understanding. In supporting this direction, Ionic Global shared perspectives on wound care management, including the importance of maintaining a clean wound environment and managing microbial load—factors widely recognised to influence healing outcomes. Within this context, attention was given to approaches that support effective antimicrobial hygiene while preserving tissue viability, an important balance in modern wound care. This includes the application of Malaysia Homegrown IGTech, Ionic Global’s proprietary technology platform, which underpins the development of the high purity hypochlorous acid (HOCl)-based solutions. HOCl is described in scientific literature as an endogenous antimicrobial agent involved in the body’s innate immune response. At appropriate concentrations, it has been associated with broad-spectrum antimicrobial activity and rapid microbial reduction under controlled conditions, while maintaining a favourable tissue compatibility profile. As the core technology behind Antaviro Wound Care, IGTech is designed to support hygienic wound conditions as part of an integrated and clinically guided care approach—contributing to microbial load management while aligning with principles of tissue preservation and patient comfort. These discussions mark an important step towards the development of a structured “Best Practice” standard procedure framework, aimed at enhancing consistency, safety, and clinical effectiveness in circumcision-related care. The proposed framework will incorporate clinical observations, practitioner feedback, and data-informed insights, forming a practical reference to support healthcare providers in delivering more standardised care. As part of this initiative, a comprehensive proposal is currently being developed and will be submitted to MADOCS in early May 2026, with the intention of supporting further review and potential consideration by the Ministry of Health Malaysia. This reflects a shared aspiration to contribute meaningfully to the evolution of clinical standards at a broader, national level. Beyond the technical discussions, this engagement also highlights the importance of collaboration between industry and healthcare professionals. By creating platforms for open dialogue, shared learning, and continuous improvement, Ionic Global aims to play a supportive role in strengthening clinical practice and advancing patient care. At Ionic Global, we remain humbled by the opportunity to contribute alongside dedicated healthcare practitioners. Through ongoing engagement, responsible innovation, and a commitment to evidence-informed practices, we strive to support a healthcare ecosystem that is more consistent, more informed, and ultimately more patient-centred. As we move forward, we look to these collaborations as building blocks for long-term impact—where knowledge, care, and collaboration come together to shape a better future for healthcare in Malaysia.

CSR Project, Event

Advancing Community Healthcare Through Strategic PartnershipAdvancing Community Healthcare: Ionic Global Partners PERDIM to Elevate Wound Care Standards in MalaysiaAdvancing Community Healthcare Through Strategic Partnership

Ionic Global collaborates with PERDIM to promote wound care awareness, clinical education, and Antaviro HOCl-based antimicrobial solutions—advancing healthcare standards and community well-being in Malaysia. Advancing Community Healthcare Through Strategic Collaboration At Ionic Global Sdn Bhd (IG), we believe that true progress begins with giving back to the communities we serve. Guided by this principle, we are honoured to mark a significant milestone on 25 April 2026 with the signing of a Memorandum of Understanding (MOU) with PERDIM (Pertubuhan Doktor-Doktor Islam Malaysia), representing approximately 1,200 private clinics nationwide. This strategic collaboration reflects a shared commitment to advancing community healthcare through structured Corporate Social Responsibility (CSR) initiatives. By combining clinical expertise, professional networks, and innovation-driven solutions, Ionic Global and PERDIM aim to strengthen awareness and adoption of proper wound care management—an essential component in improving patient outcomes yet often underemphasised at the community level. Central to this partnership is a focus on education, training, and the development of more consistent, evidence-informed practices. Through targeted programmes, practitioner engagement, and knowledge-sharing platforms, both parties seek to enhance clinical understanding while empowering healthcare providers with practical approaches to wound care that prioritise safety, effectiveness, and patient well-being. Supporting these efforts is Ionic Global’s continued advancement in antimicrobial wound hygiene, particularly through the application of hypochlorous acid (HOCl) technology. Recognised in scientific literature as a naturally occurring antimicrobial agent involved in the body’s innate immune response, HOCl demonstrates broad-spectrum antimicrobial activity against common wound pathogens. At controlled concentrations, it has been associated with rapid microbial reduction under appropriate conditions, while maintaining favourable tissue compatibility and low cytotoxicity—key considerations in preserving viable tissue during the healing process. As the key active component in Antaviro Wound Care, IGTech Antimicrobial Solution—powered by hypochlorous acid (HOCl)—is designed to support hygienic wound environments by contributing to microbial load management and helping to mitigate biofilm-prone conditions, which are commonly associated with delayed healing. This approach aligns with contemporary wound care principles that emphasise maintaining a balanced wound environment to support natural healing progression. Within the context of this collaboration, both Ionic Global and PERDIM will work towards building a growing body of clinical insights through practitioner feedback, observational data, and structured engagement initiatives. These efforts are complemented by awareness campaigns and training sessions aimed at improving sensitivity, consistency, and confidence in wound care practices. By leveraging PERDIM’s extensive professional network and communication platforms, the collaboration seeks to extend its impact beyond clinical settings and into the broader community. The MOU signing took place during PERDIM’s Annual Raya celebration, where Ionic Global was represented by Director, Mr. Baharinshah Hussain, alongside Business Development Advisor, Mdm Monica Low. In conjunction with the celebration, Ionic Global also presented 10 Raya gift hampers featuring Antaviro Wound Care and the Ombac+ product series—including Instant Hygiene Spray, Feminine Care, Men Care, and Fur Fur Pet Care—as a gesture of appreciation to the medical community for their continued dedication and service. This partnership represents more than a formal agreement—it reflects a shared purpose to contribute meaningfully to healthcare development in Malaysia. Through collaboration, continuous learning, and responsible innovation, Ionic Global remains committed to supporting improved clinical practices, enhancing patient care, and fostering a more informed and resilient healthcare ecosystem. As we move forward, we look to this collaboration as a foundation for long-term impact—one that brings together science, care, and community to shape a healthier future for all.

Market Review

Latest COVID-19 Variant Update: Staying Informed, Staying Protected

Latest COVID-19 Variant Update: Staying Informed, Staying Protected As the global health landscape continues to evolve, a new COVID-19 subvariant, BA.3.2—informally referred to as “Cicada”—is currently under observation across multiple countries. As part of the Omicron family, this subvariant reflects the natural progression of viral mutations, with early indications suggesting it may spread more easily and exhibit partial immune escape. Despite these developments, current data provides reassurance. There is no clear evidence that BA.3.2 leads to more severe illness. Reported symptoms remain consistent with earlier Omicron variants, including sore throat, cough, fever, and fatigue. Importantly, vaccination continues to play a critical role in reducing the risk of severe outcomes and hospitalisation. The emergence of new variants highlights the importance of sustained public awareness and everyday protective practices. Maintaining good hygiene, especially in shared and high-contact environments, remains a key line of defence in reducing transmission. In this context, Ionic Global Sdn Bhd continues to support community health through safe and effective hygiene solutions. Powered by advanced HOCl technology, products such as Ombac+ Instant Hygiene Spray and Ombac+ Ultron provide reliable antimicrobial protection for both personal use and surface disinfection. Their non-toxic and gentle formulation allows for frequent use, making them suitable for daily protection in homes, workplaces, and public spaces. As we adapt to an endemic environment, the focus shifts from fear to preparedness. Staying informed, practicing consistent hygiene, and leveraging safe, science-backed solutions are essential steps toward safeguarding individual and community well-being. Together, through awareness and responsible action, we can continue to navigate these changes with confidence and resilience. Source: New COVID variant “Cicada” spreads across US – key facts and symptoms

Market Review

HOCl Market Growth & Industry Outlook (2025–2034)

HOCl Market Growth& Industry Outlook (2025–2034) According to Fortune Business Insights in its Hypochlorous Acid Market Report (2025), the global HOCl market was valued at approximately USD 1.90 billion in 2025 and is projected to reach USD 3.32 billion by 2034, growing at a CAGR of 6.4%. Asia Pacific led the market in 2025, accounting for 30.53% of total market share. The report highlights that the healthcare and wound/skin care segment continues to dominate the global HOCl market, reflecting the rising importance of safe, effective, and clinically aligned antimicrobial solutions. Hypochlorous acid (HOCl) is widely positioned for wound and skin antisepsis, where its gentle tissue compatibility and non-toxic profile make it highly suitable for modern healthcare and personal care applications. This segment benefits from stronger value positioning, supported by stringent quality standards, regulatory considerations, and diversified channels across clinics, pharmacies, and branded consumer products. It is projected to grow at a CAGR of 6.6% over the forecast period. Beyond healthcare, demand for HOCl is also expanding across household and institutional settings, driven by increasing preference for low-odor, low-residue disinfecting solutions. This segment is expected to grow at a CAGR of 5.8%, supported by broader retail availability and rising hygiene awareness across homes, workplaces, and public facilities. Meanwhile, the food processing and agriculture sectors remain important contributors, with HOCl widely used in wash and process water systems. Adoption is further supported by regulatory clarity for electrolytically generated HOCl, enabling efficient, scalable, and residue-conscious sanitation in high-throughput environments. In line with these market trends, Ionic Global Sdn Bhd is strategically positioned to serve high-value application segments through its IGTECH high-purity HOCl technology. The company’s Antaviro wound care range is designed for clinical-grade wound management, addressing the dual priorities of safety and efficacy in healthcare settings. Meanwhile, the Ombac+ series extends into personal care, household, and environmental hygiene, meeting the growing demand for gentle, effective, and residue-free disinfection solutions. By integrating high-purity HOCl technology with a diversified application portfolio, Ionic Global not only aligns with evolving market dynamics but also contributes to advancing HOCl from conventional disinfection toward higher-standard medical and lifestyle applications. This strengthens the company’s position in next-generation antimicrobial innovation. As industries continue to shift toward safer and more sustainable disinfection technologies, high-purity HOCl solutions powered by IGTECH are well-positioned to meet expanding needs across healthcare, hygiene, and environmental sectors. Ionic Global Sdn Bhd plays a growing role in advancing hypochlorous acid (HOCl) solutions in Malaysia, supporting the nation’s increasing emphasis on healthcare quality, public hygiene, and sustainable disinfection practices. Leveraging its IGTECH high-purity HOCl technology, the company is positioned to bridge clinical-grade standards with everyday applications, ensuring that safe, effective, and non-toxic antimicrobial solutions are accessible across both medical and community settings. In the healthcare sector, Ionic Global’s Antaviro Wound Care range is developed to support clinical wound management with a focus on safety, efficacy, and patient comfort. Designed for use in managing acute and chronic wounds, Antaviro utilizes high-purity HOCl to help reduce microbial load while maintaining gentle tissue compatibility—an important factor in supporting healing outcomes. By aligning with modern wound care practices, Antavirocontributes to improving patient care standards in clinics, pharmacies, and home-based treatment environments. Beyond healthcare, Ionic Global extends its impact into the community through Ombac+ Instant Hygiene Spray, providing a convenient and reliable solution for everyday protection. Suitable for personal, household, and public use, Ombac+ is formulated to deliver effective disinfection with low odor and no harmful residue, making it ideal for frequent use in shared spaces. As awareness of hygiene and infection prevention continues to grow in Malaysia, Ombac+ supports a safer environment by empowering individuals and communities with practical, science-based protection. Source: Fortune Business Insights, Hypochlorous Acid Market Report (2025).

Scroll to Top